These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 32740083

  • 1. Biochemical Diagnosis of Bile Acid Diarrhea: Prospective Comparison With the 75Seleno-Taurohomocholic Acid Test.
    Borup C, Wildt S, Rumessen J, Graff J, Bouchelouche PN, Andersen TB, Vinter-Jensen L, Zaremba A, German Jørgensen SP, Gregersen T, Nøjgaard C, Timm HB, Rainteau D, Gauliard E, Munck LK.
    Am J Gastroenterol; 2020 Dec; 115(12):2086-2094. PubMed ID: 32740083
    [Abstract] [Full Text] [Related]

  • 2. Fibroblast growth factor 19 in patients with bile acid diarrhoea: a prospective comparison of FGF19 serum assay and SeHCAT retention.
    Pattni SS, Brydon WG, Dew T, Johnston IM, Nolan JD, Srinivas M, Basumani P, Bardhan KD, Walters JR.
    Aliment Pharmacol Ther; 2013 Oct; 38(8):967-76. PubMed ID: 23981126
    [Abstract] [Full Text] [Related]

  • 3. Serum Concentrations of 7α-hydroxy-4-cholesten-3-one Are Associated With Bile Acid Diarrhea in Patients With Crohn's Disease.
    Battat R, Duijvestein M, Vande Casteele N, Singh S, Dulai PS, Valasek MA, Mimms L, McFarland J, Hester KD, Renshaw M, Jain A, Sandborn WJ, Boland BS.
    Clin Gastroenterol Hepatol; 2019 Dec; 17(13):2722-2730.e4. PubMed ID: 30448597
    [Abstract] [Full Text] [Related]

  • 4. Chenodeoxycholic acid stimulated fibroblast growth factor 19 response - a potential biochemical test for bile acid diarrhoea.
    Borup C, Wildt S, Rumessen JJ, Bouchelouche PN, Graff J, Damgaard M, McQuitty C, Rainteau D, Munck LK.
    Aliment Pharmacol Ther; 2017 Jun; 45(11):1433-1442. PubMed ID: 28378364
    [Abstract] [Full Text] [Related]

  • 5. A new mechanism for bile acid diarrhea: defective feedback inhibition of bile acid biosynthesis.
    Walters JR, Tasleem AM, Omer OS, Brydon WG, Dew T, le Roux CW.
    Clin Gastroenterol Hepatol; 2009 Nov; 7(11):1189-94. PubMed ID: 19426836
    [Abstract] [Full Text] [Related]

  • 6. Prospective comparison of diagnostic tests for bile acid diarrhoea.
    Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Andersen TB, Nøjgaard C, Timm HB, Lamazière A, Rainteau D, Hansen SH, Rumessen JJ, Munck LK.
    Aliment Pharmacol Ther; 2024 Jan; 59(1):39-50. PubMed ID: 37794830
    [Abstract] [Full Text] [Related]

  • 7. Serum 7 alpha-hydroxy-4-cholesten-3-one and selenohomocholyltaurine (SeHCAT) whole body retention in the assessment of bile acid induced diarrhoea.
    Brydon WG, Nyhlin H, Eastwood MA, Merrick MV.
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):117-23. PubMed ID: 8723414
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterizing Factors Associated With Differences in FGF19 Blood Levels and Synthesis in Patients With Primary Bile Acid Diarrhea.
    Johnston IM, Nolan JD, Pattni SS, Appleby RN, Zhang JH, Kennie SL, Madhan GK, Jameie-Oskooei S, Pathmasrirengam S, Lin J, Hong A, Dixon PH, Williamson C, Walters JR.
    Am J Gastroenterol; 2016 Mar; 111(3):423-32. PubMed ID: 26856750
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Diagnosis of bile acid diarrhoea by fasting and postprandial measurements of fibroblast growth factor 19.
    Borup C, Syversen C, Bouchelouche P, Damgaard M, Graff J, Rumessen JJ, Munck LK.
    Eur J Gastroenterol Hepatol; 2015 Dec; 27(12):1399-402. PubMed ID: 26426834
    [Abstract] [Full Text] [Related]

  • 12. Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.
    Vijayvargiya P, Camilleri M, Carlson P, Lueke A, O'Neill J, Burton D, Busciglio I, Donato L.
    Aliment Pharmacol Ther; 2017 Sep; 46(6):581-588. PubMed ID: 28691284
    [Abstract] [Full Text] [Related]

  • 13. Defining primary bile acid diarrhea: making the diagnosis and recognizing the disorder.
    Walters JR.
    Expert Rev Gastroenterol Hepatol; 2010 Oct; 4(5):561-7. PubMed ID: 20932141
    [Abstract] [Full Text] [Related]

  • 14. Fibroblast Growth Factor 19 and 7α-Hydroxy-4-Cholesten-3-one in the Diagnosis of Patients With Possible Bile Acid Diarrhea.
    Pattni SS, Brydon WG, Dew T, Walters JR.
    Clin Transl Gastroenterol; 2012 Jul 26; 3(7):e18. PubMed ID: 23238290
    [Abstract] [Full Text] [Related]

  • 15. Efficacy and safety of colesevelam for the treatment of bile acid diarrhoea: a double-blind, randomised, placebo-controlled, phase 4 clinical trial.
    Borup C, Vinter-Jensen L, Jørgensen SPG, Wildt S, Graff J, Gregersen T, Zaremba A, Borup Andersen T, Nøjgaard C, Timm HB, Rainteau D, Hansen SH, Rumessen JJ, Munck LK.
    Lancet Gastroenterol Hepatol; 2023 Apr 26; 8(4):321-331. PubMed ID: 36758570
    [Abstract] [Full Text] [Related]

  • 16. Methods for diagnosing bile acid malabsorption: a systematic review.
    Lyutakov I, Ursini F, Penchev P, Caio G, Carroccio A, Volta U, De Giorgio R.
    BMC Gastroenterol; 2019 Nov 14; 19(1):185. PubMed ID: 31726982
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.